Efficacy and Safety of Perampanel Monotherapy in Patients Aged >= 12 to < 18 Years with Newly Diagnosed/currently Untreated Recurrent Focal-onset Seizures (FOS): FREEDOM Study 342
PEDIATRICS（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined